老年心脏重症患者主动脉内球囊反搏术的应用及预后分析

吴雪萍; 曹 剑; 朱 平; 刘宏伟; 汪 霞

PDF(518 KB)

武警医学 ›› 2012, Vol. 23 ›› Issue (10) : 833-835.

论著

老年心脏重症患者主动脉内球囊反搏术的应用及预后分析

吴雪萍,曹剑,朱平,刘宏伟,汪霞

作者信息 +

Intra-aortic balloon pump application and outcomes in elderly patients

First Cardiovascular Department in Southern Building,General Hospital of PLA,Beijing 100853,China

Author information +

文章历史 +

摘要

目的探讨老年心脏重症患者主动脉内球囊反搏术(intra-aortic balloon pump，IABP)治疗的应用、临床预后及并发症。方法回顾性分析我院老年病房接受IABP治疗的48例患者的临床资料。将患者分为死亡组及存活组，分析治疗效果的相关因素及并发症。结果接受IABP治疗患者总病死率39.6%；存活组再血管化成功率为62.1%，明显高于死亡组26.3%；而有陈旧性心梗病史率低于死亡组（P<0.01）。总并发症率16.7%，以出血最常见。此外，多因素Logistic 回归分析，结果表明陈旧性心梗史、心源性休克与院内病死率正相关，而成功再血管化则与其负相关。结论老年人心源性休克、陈旧性心梗史及成功再血管化是影响老年人心血管重症接受IABP治疗院内病死率的重要因素。

Abstract

Objective To analyze the outcomes and complications of the intra-aortic balloon pump (IABP) in elderly patients with severe heart disease. Methods A retrospective study of 48 consecutive patients who received IABP therapy was conducted. Based on prognosis, two groups were defined: surviving group and non-surviving group. Results The overall mortality was 39.6%, There was a higher rate of successful revascularization(62.1% versus 26.3%) and fewer cases of previous myocardial infarction history (10.3% versus 47.4%) in surviving group than in non-survival group

关键词

主动脉内球囊反搏 / 老年 / 预后

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

吴雪萍,曹剑,朱平,刘宏伟,汪霞. 老年心脏重症患者主动脉内球囊反搏术的应用及预后分析[J]. 武警医学. 2012, 23(10): 833-835

WU Xueping,CAO Jian,ZHU Ping,LIU Hongwei,WANG Xia. Intra-aortic balloon pump application and outcomes in elderly patients[J]. Medical Journal of the Chinese People Armed Police Forces. 2012, 23(10): 833-835

中图分类号： R541

参考文献

［1］ Sanborn T A, Sleeper L A, Bates E R, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularized Occluded Coronaries for cardiogenic shock? ［J］. J Am Coll Cardiol, 2000, 36(3): 1123-1129.

［2］ Vales L, Kanei Y, Ephrem G, et al. Intra-aortic balloon pump use and outcomes with current therapies［J］. J Invasive Cardiol, 2011, 23(3): 116-119.

［3］ Macas A, Bukauskas T, ukeviiené I, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock ［J］. Medicina (Kaunas), 2011, 47(4): 212-218.

［4］ Stone G W, Ohman E M, Miller M F, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry ［J］. J Am Coll Cardiol, 2003, 41(11): 1940-1945.

［5］ Castelli P, Condemi A, Munari M, et al. Intra-aortic balloon counterpulsation: outcome in cardiac surgical patients［J］. J Cardiothorac Vasc Anesth, 2001, 15(6): 700-703.

［6］ Vandenplas G, Bove T, Case F, et al. Ten years single-center experience with intra-aortic balloon pump［J］. Acta Cardiol, 2011, 66(6): 707-713.

［7］ Severi L, Vaccaro P, Covotta M, et al. Severe intra-aortic balloon pump complications: a single-center 12-year experience［J］. J Cardiothorac Vasc Anesth, 2012, 26(4): 604-607.

［8］ Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump Intra-aortic balloon pump use and outcomes with current therapies［J］. J Cardiothorac Surg, 2011, 11(6): 147-152.

［9］ Alvarez J M, Gates R, Rowe D, et al. Complications from intra-aortic balloon counterpulsation: a review of 303 cardiac surgical patients ［J］. Eur J Cardiothorac Surg, 1992, 6(10), 530-535.

［10］ Kumbasar S D, Semiz E, Sancaktar O, et al. Mechanical complications of intra-aortic balloon counterpulsation ［J］. Int J Cardiol, 1999, 70(1): 69-73.